美國氧氣濃縮機市場：市場規模、佔有率、趨勢分析（按產品、應用和技術分類）、細分市場預測（2025-2033 年）

美國氧氣濃縮機市場摘要

據估計，2024 年美國氧氣濃縮機市值為 15.5 億美元，預計到 2033 年將達到 30.9 億美元，2025 年至 2033 年的複合年成長率為 7.6%。

這是由於慢性阻塞性肺病、氣喘和睡眠呼吸中止症等呼吸系統疾病的日益普遍、醫療保健支出不斷增加、研發投入巨大、醫療保健基礎設施先進、能夠獲得最新技術以及新產品推出等原因造成的。

根據對聯邦醫療保險（Medicare）理賠數據的分析，攜帶式氧氣濃縮機（POC）在美國醫療保險滲透率正在穩步上升。例如，2021年POC的滲透率為22.0%，而固定式製氧機的滲透率僅為17%。這一發展趨勢顯示攜帶式氧氣濃縮機（POC）的普及程度高於固定式氧氣濃縮機，從而推動了美國氧氣濃縮機產業的擴張。

政府的支持，例如美國聯邦航空管理局（FAA）核准攜帶式氧氣濃縮機用於航空旅行，進一步推動了該地區的成長。此外，優惠的報銷政策也使美國的氧氣濃縮機市場更具吸引力。例如，2024年3月，美國眾議院提出了《補充氧氣取得改革法案》（SOAR），旨在改革和改善聯邦醫療保險受益人獲得補充氧氣的​​途徑。此外，美國醫療保健支出的成長也推動了對呼吸系統疾病有效診斷和治療的需求，從而促進了氧氣濃縮機市場的發展。

慢性呼吸系統疾病，尤其是慢性阻塞性肺病（COPD）的日益流行，是美國氧氣濃縮機市場的主要驅動力。 COPD影響超過5%的美國成年人，每年造成近500億美元的經濟損失，推動了對有效氧氣療法解決方案的需求不斷成長。臨床研究已證實，長期氧氣療法能夠改善低氧血症患者的預後，因此氧氣濃縮機已成為疾病管理的重要組成部分。

此外，傳統供氧方式（例如固定式供氧系統和氧氣罐）的局限性，例如限制患者活動範圍且需要頻繁補充氧氣，正推動攜帶式氧氣濃縮機的發展。這些設備為患者提供了更大的獨立性和靈活性，同時有效應對了慢性阻塞性肺病、囊腫纖維化和心臟衰竭等疾病日益嚴重的低氧血症問題，從而促進了其在美國市場的普及。

目錄

第1章 分析方法和範圍

第2章執行摘要

第3章 市場因素、趨勢與範圍

• 市場關聯性展望
• 市場動態
  • 市場促進因素分析
  • 呼吸系統疾病（慢性阻塞性肺病、氣喘、睡眠呼吸中止症等）盛行率不斷上升
  • 居家醫療的普及
  • 氧氣濃縮機的技術進步
  • 推出新世代產品並拓展業務
  • 市場限制因素分析
  • 氧氣濃縮機的高成本
  • 產業機會分析
  • 產業問題分析
  • 案例研究
• 商業環境分析
  • 波特五力分析
  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新參與企業的威脅
  • 競爭對手之間的競爭
  • PESTEL 分析
  • 政治因素
  • 經濟和社會因素
  • 技術因素
  • 環境因素
  • 法律因素

第4章：美國氧氣濃縮機市場：按產品分類的估算與趨勢分析

• 產品儀錶板
• 市佔率變化分析：依產品分類（2024 年及 2033 年）
• 按產品分類的市場規模預測和趨勢分析（2021-2033）
• 攜帶式/醫用氧氣濃縮機
• 固定式醫用氧氣濃縮機

第5章：美國氧氣濃縮機市場：按應用分類的估算和趨勢分析

• 特定用途的儀錶板
• 市場佔有率變化分析：按應用領域分類（2024 年和 2033 年）
• 按應用領域分類的市場規模預測和趨勢分析（2021-2033）
• 居家醫療
• 除了居家醫療之外

第6章：美國氧氣濃縮機市場：依技術分類的估算與趨勢分析

• 技術儀錶板
• 市場佔有率變化分析：依技術分類（2024 年和 2033 年）
• 按技術分類的市場規模預測和趨勢分析（2021-2033）
• 連續流型
• 脈動流型

第7章美國氧氣濃縮機市場：競爭格局

• 參與企業概況
• 按產品類型分類的公司市佔率分析（2021-2024）
• 氧氣濃縮機市場規模（以銷量計）和平均售價（ASP）趨勢（2021-2024 年）
• 公司分類
• 策略規劃
• 公司簡介/上市公司

U.S. Oxygen Concentrator Market Summary

The U.S. oxygen concentrator market size was estimated at USD 1.55 billion in 2024 and is projected to reach USD 3.09 billion by 2033, growing at a CAGR of 7.6% from 2025 to 2033. The increase in the prevalence of respiratory conditions such as COPD, asthma, and sleep apnea, rising healthcare spending, significant investment in R&D, advanced healthcare infrastructure, access to the newest technology, and new product launches.

According to the analyzed Medicare claims data, the Medicare penetration rate for portable oxygen concentrators (POCs) in the U.S. has steadily risen. For instance, in 2021, the POC penetration was 22.0%, while that of stationary was 17%. This is a developing trend favoring portable oxygen concentrators (POCs) over fixed oxygen concentrators and fueling the expansion of the U.S. oxygen concentrator industry.

Government support, such as the Federal Aviation Administration's (FAA) approval of portable concentrators during plane travel, further drives the region's growth. Furthermore, favorable reimbursement policies have enhanced the attractiveness of the U.S. oxygen concentrators market. For instance, in March 2024, a U.S. Congressman introduced the Supplemental Oxygen Access Reform (SOAR) Act to reform and improve access to supplementary oxygen for Medicare beneficiaries. These policies have increased the adoption of oxygen concentrators in the U.S. In addition, rising healthcare spending in the U.S. is driving the demand for effective diagnosis and treatment of respiratory diseases, thereby boosting the market for oxygen concentrators.

The rising prevalence of chronic respiratory diseases, particularly chronic obstructive pulmonary disease (COPD), is a key driver of the U.S. oxygen concentrator market. With COPD affecting over 5% of U.S. adults and contributing to nearly USD 50 billion in annual economic costs, the demand for effective oxygen therapy solutions continues to grow. Long-term oxygen therapy has been clinically proven to improve outcomes in hypoxemic patients, making oxygen concentrators an essential part of disease management.

Moreover, limitations of traditional oxygen delivery methods, such as stationary systems and oxygen cylinders that restrict mobility and require frequent refills, accelerate the shift toward portable oxygen concentrators. These devices provide patients with greater independence and flexibility while addressing the increasing burden of COPD, cystic fibrosis, and heart failure-related hypoxemia, thereby fueling adoption across the U.S. market.

U.S. Oxygen Concentrator Market Report Segmentation

This report forecasts volume & revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. oxygen concentrator market report based on product, application, and technology:

• Product Outlook (Volume, Unit; Revenue, USD Million, 2021 - 2033)
• Portable Medical Oxygen Concentrators
• Fixed Medical Oxygen Concentrators
• Application Outlook (Volume, Unit; Revenue, USD Million, 2021 - 2033)
• Home Care
• Non-Home Care
• Technology Outlook (Volume, Unit; Revenue, USD Million, 2021 - 2033)
• Continuous Flow
• Pulse Flow

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Application
  • 1.2.3. Technology
• 1.3. Estimates and Forecast Timeline
• 1.4. Research Methodology
• 1.5. Information Procurement
  • 1.5.1. Purchased Database
  • 1.5.2. GVR's Internal Database
  • 1.5.3. Secondary Sources
  • 1.5.4. Primary Research
• 1.6. Information Analysis
  • 1.6.1. Data Analysis Models
• 1.7. Market Formulation & Data Visualization
• 1.8. Model Details
  • 1.8.1. Commodity Flow Analysis
• 1.9. List of Secondary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Increase in the prevalence of respiratory conditions such as COPD, asthma, and sleep apnea.
  • 3.2.3. Growing adoption of home healthcare
  • 3.2.4. Technological advancements in oxygen concentrators
  • 3.2.5. Launch of new generation products and increasing business expansion
  • 3.2.6. Market Restraint Analysis
  • 3.2.7. High cost associated with oxygen concentrators
  • 3.2.8. Industry Opportunity Analysis
  • 3.2.9. Industry Challenge Analysis
  • 3.2.10. Case Studies
• 3.3. Business Environment Analysis
  • 3.3.1. Porter's Five Forces Analysis
  • 3.3.2. Supplier power
  • 3.3.3. Buyer power
  • 3.3.4. Substitution threat
  • 3.3.5. Threat of new entrant
  • 3.3.6. Competitive rivalry
  • 3.3.7. PESTLE Analysis
  • 3.3.8. Political landscape
  • 3.3.9. Economic and Social landscape
  • 3.3.10. Technological landscape
  • 3.3.11. Environmental landscape
  • 3.3.12. Legal Landscape

Chapter 4. U.S. Oxygen Concentrator Systems Market: Product Estimates & Trend Analysis

• 4.1. Product Segment Dashboard
• 4.2. Product Market Share Movement Analysis, 2024 & 2033
• 4.3. Market Size & Forecasts and Trend Analysis, by Product, 2021 to 2033 (USD Million, Unit Volume 000')
• 4.4. Portable Medical Oxygen Concentrators
  • 4.4.1. Market estimates and forecast 2021 to 2033 (USD Million)
  • 4.4.2. Market estimates and forecast 2021 to 2033 (Unit Volume 000')
• 4.5. Fixed Medical Oxygen Concentrators
  • 4.5.1. Market estimates and forecast 2021 to 2033 (USD Million)
  • 4.5.2. Market estimates and forecast 2021 to 2033 (Unit Volume 000')

Chapter 5. U.S. Oxygen Concentrator Market: Application Estimates & Trend Analysis

• 5.1. Application Segment Dashboard
• 5.2. Application Market Share Movement Analysis, 2024 & 2033
• 5.3. Market Size & Forecasts and Trend Analysis, by Application, 2021 to 2033 (USD Million)
• 5.4. Home Care
  • 5.4.1. Market estimates and forecast 2021 to 2033 (USD Million)
• 5.5. Non-Home Care
  • 5.5.1. Market estimates and forecast 2021 to 2033 (USD Million)

Chapter 6. U.S. Oxygen Concentrator Market: Technology Estimates & Trend Analysis

• 6.1. Technology Segment Dashboard
• 6.2. Technology Market Share Movement Analysis, 2024 & 2033
• 6.3. Market Size & Forecasts and Trend Analysis, by Technology, 2021 to 2033 (USD Million)
• 6.4. Continuous flow
  • 6.4.1. Market estimates and forecast 2021 to 2033 (USD Million)
• 6.5. Pulse Flow
  • 6.5.1. Market estimates and forecast 2021 to 2033 (USD Million)

Chapter 7. U.S. Oxygen Concentrator Market: Competitive Landscape

• 7.1. Participant Overview
• 7.2. Company Market Share Analysis (2021 - 2024), by product type
  • 7.2.1. Portable Medical Oxygen Concentrators (Value USD Million)
  • 7.2.2. Fixed Medical Oxygen Concentrators (Value USD Million)
• 7.3. Volume Analysis with ASP Trends (2021 - 2024) at oxygen concentrators
  • 7.3.1. Portable Medical Oxygen Concentrators (Unit Volume 000')
  • 7.3.2. Fixed Medical Oxygen Concentrators (Unit Volume 000')
• 7.4. Company Categorization
• 7.5. Strategy Mapping
• 7.6. Company Profiles/Listing
  • 7.6.1. Respironics (a subsidiary of Koninklijke Philips N.V.) {Effective from January 25, 2024, Philips Respironics halted the sale of their POCs, with end of service scheduled for January 25, 2029.}
    • 7.6.1.1. Overview
    • 7.6.1.2. Financial performance
    • 7.6.1.3. Products benchmarking
    • 7.6.1.4. Strategic initiatives
  • 7.6.2. Direct Supply
    • 7.6.2.1. Overview
    • 7.6.2.2. Financial performance
    • 7.6.2.3. Products benchmarking
    • 7.6.2.4. Strategic initiatives
  • 7.6.3. GF Health Products, Inc.
    • 7.6.3.1. Overview
    • 7.6.3.2. Financial performance
    • 7.6.3.3. Products benchmarking
    • 7.6.3.4. Strategic initiatives
  • 7.6.4. MedaCure Inc.
    • 7.6.4.1. Overview
    • 7.6.4.2. Financial performance
    • 7.6.4.3. Products benchmarking
    • 7.6.4.4. Strategic initiatives
  • 7.6.5. Nidek Medical Products, Inc
    • 7.6.5.1. Overview
    • 7.6.5.2. Financial performance
    • 7.6.5.3. Products benchmarking
    • 7.6.5.4. Strategic initiatives
  • 7.6.6. O2 Concepts
    • 7.6.6.1. Overview
    • 7.6.6.2. Financial performance
    • 7.6.6.3. Products benchmarking
    • 7.6.6.4. Strategic initiatives
  • 7.6.7. React Health
    • 7.6.7.1. Overview
    • 7.6.7.2. Financial performance
    • 7.6.7.3. Products benchmarking
    • 7.6.7.4. Strategic initiatives
  • 7.6.8. CAIRE Inc. (Acquired by Niterra Co., Ltd., formerly known as NGK SPARK PLUG CO., LTD.)
    • 7.6.8.1. Overview
    • 7.6.8.2. Financial performance
    • 7.6.8.3. Products benchmarking
    • 7.6.8.4. Strategic initiatives
  • 7.6.9. DeVilbiss Healthcare (a subsidiary of Drive Medical)
    • 7.6.9.1. Overview
    • 7.6.9.2. Financial performance
    • 7.6.9.3. Products benchmarking
    • 7.6.9.4. Strategic initiatives
  • 7.6.10. GCE Group
    • 7.6.10.1. Overview
    • 7.6.10.2. Financial performance
    • 7.6.10.3. Products benchmarking
  • 7.6.11. Compass Health Brands
    • 7.6.11.1. Overview
    • 7.6.11.2. Financial performance
    • 7.6.11.3. Products benchmarking

List of Tables

• Table 1 List of secondary sources
• Table 2 List of abbreviations
• Table 3 US Oxygen concentrator market, product, 2021 - 2033 (USD Million)
• Table 4 US Oxygen concentrator market, product, 2021 - 2033 (Unit Volume 000')
• Table 5 US Oxygen concentrator market, by application, 2021 - 2033 (USD Million)
• Table 6 US Oxygen concentrator market, by technology, 2021 - 2033 (USD Million)

List of Figures

• Fig. 1 US Oxygen Concentrator Market Segmentation
• Fig. 2 Market research process
• Fig. 3 Data triangulation techniques
• Fig. 4 Primary research pattern
• Fig. 5 Market formulation & validation
• Fig. 6 Market research approaches
• Fig. 7 Value-chain-based sizing & forecasting
• Fig. 8 QFD modelling for market share assessment
• Fig. 9 Commodity flow analysis
• Fig. 10 Market snapshot
• Fig. 11 Market segmentation (USD Million)
• Fig. 12 Competitive landscape
• Fig. 13 Parent market outlook (In USD Million)
• Fig. 14 Related/ancillary market outlook (In USD Million)
• Fig. 15 US oxygen concentrator market dynamics
• Fig. 16 US oxygen concentrator market: Porter's five forces analysis
• Fig. 17 US oxygen concentrator market: PESTLE analysis
• Fig. 18 US oxygen concentrator market: Product segment dashboard
• Fig. 19 US oxygen concentrator market: Product market share analysis, 2024 & 2033
• Fig. 20 Portable medical oxygen concentrators market, 2021 - 2033 (USD Million)
• Fig. 21 Portable medical oxygen concentrators market, 2021 - 2033 (Unit Volume 000')
• Fig. 22 Fixed medical oxygen concentrators market, 2021 - 2033 (USD Million)
• Fig. 23 Fixed medical oxygen concentrators market, 2021 - 2033 (Unit Volume 000')
• Fig. 24 US oxygen concentrator market: Application dashboard
• Fig. 25 US oxygen concentrator market: Application market share analysis, 2024 & 2033
• Fig. 26 Home care market, 2021 - 2033 (USD Million)
• Fig. 27 Non-home care market, 2021 - 2033 (USD Million)
• Fig. 28 US oxygen concentrator market: Technology segment dashboard
• Fig. 29 Continuous flow market, 2021 - 2033 (USD Million)
• Fig. 30 Pluse flow market, 2021 - 2033 (USD Million)
• Fig. 31 Company categorization
• Fig. 32 Company market share analysis
• Fig. 33 Strategic framework